Lind GE - Search Results

1

Unraveling epigenetic heterogeneity across gastrointestinal adenocarcinomas through a standardized analytical framework.

Pinto R, Vedeld HM, Lind GE, Jeanmougin M. Pinto R, et al. Among authors: lind ge. Mol Oncol. 2024 Dec 18. doi: 10.1002/1878-0261.13772. Online ahead of print. Mol Oncol. 2024. PMID: 39696831 Free article.

2

Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer.

Vedeld HM, Pharo H, Sørbø AK, Brandt-Winge S, Five MB, Jeanmougin M, Guldberg P, Wahlqvist R, Lind GE. Vedeld HM, et al. Among authors: lind ge. Mol Oncol. 2024 Nov;18(11):2684-2695. doi: 10.1002/1878-0261.13639. Epub 2024 May 8. Mol Oncol. 2024. PMID: 38720532 Free PMC article.

3

The recently suggested intestinal cancer stem cell marker DCLK1 is an epigenetic biomarker for colorectal cancer.

Vedeld HM, Skotheim RI, Lothe RA, Lind GE. Vedeld HM, et al. Among authors: lind ge. Epigenetics. 2014 Mar;9(3):346-50. doi: 10.4161/epi.27582. Epub 2014 Jan 2. Epigenetics. 2014. PMID: 24384857 Free PMC article.

4

The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.

Vedeld HM, Andresen K, Eilertsen IA, Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO, Boberg KM, Lind GE. Vedeld HM, et al. Among authors: lind ge. Int J Cancer. 2015 Feb 15;136(4):844-53. doi: 10.1002/ijc.29039. Epub 2014 Jun 28. Int J Cancer. 2015. PMID: 24948044 Free PMC article.

5

Experimental factors affecting the robustness of DNA methylation analysis.

Pharo HD, Honne H, Vedeld HM, Dahl C, Andresen K, Liestøl K, Jeanmougin M, Guldberg P, Lind GE. Pharo HD, et al. Among authors: lind ge. Sci Rep. 2016 Sep 27;6:33936. doi: 10.1038/srep33936. Sci Rep. 2016. PMID: 27671843 Free PMC article.

6

Epigenetic biomarkers in gastrointestinal cancers: The current state and clinical perspectives.

Vedeld HM, Goel A, Lind GE. Vedeld HM, et al. Among authors: lind ge. Semin Cancer Biol. 2018 Aug;51:36-49. doi: 10.1016/j.semcancer.2017.12.004. Epub 2017 Dec 15. Semin Cancer Biol. 2018. PMID: 29253542 Free PMC article. Review.

7

Re-assessing ZNF331 as a DNA methylation biomarker for colorectal cancer.

Vedeld HM, Nesbakken A, Lothe RA, Lind GE. Vedeld HM, et al. Among authors: lind ge. Clin Epigenetics. 2018 May 29;10:70. doi: 10.1186/s13148-018-0503-2. eCollection 2018. Clin Epigenetics. 2018. PMID: 29854011 Free PMC article.

8

Improved prognostication of glioblastoma beyond molecular subtyping by transcriptional profiling of the tumor microenvironment.

Jeanmougin M, Håvik AB, Cekaite L, Brandal P, Sveen A, Meling TR, Ågesen TH, Scheie D, Heim S, Lothe RA, Lind GE. Jeanmougin M, et al. Among authors: lind ge. Mol Oncol. 2020 May;14(5):1016-1027. doi: 10.1002/1878-0261.12668. Epub 2020 Apr 4. Mol Oncol. 2020. PMID: 32171051 Free PMC article.

9

Detecting cholangiocarcinoma in patients with primary sclerosing cholangitis - The promise of DNA methylation and molecular biomarkers.

Vedeld HM, Folseraas T, Lind GE. Vedeld HM, et al. Among authors: lind ge. JHEP Rep. 2020 Jul 11;2(5):100143. doi: 10.1016/j.jhepr.2020.100143. eCollection 2020 Oct. JHEP Rep. 2020. PMID: 32939446 Free PMC article. Review.

10

Multiregional assessment of CIMP in primary colorectal cancers: Phenotype concordance but marker variability.

Flatin BTB, Vedeld HM, Pinto R, Langerud J, Lind GE, Lothe RA, Sveen A, Jeanmougin M. Flatin BTB, et al. Among authors: lind ge. Int J Cancer. 2021 Apr 1;148(7):1652-1657. doi: 10.1002/ijc.33425. Epub 2020 Dec 16. Int J Cancer. 2021. PMID: 33284993 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

88 results

Search Page

Filters